← Back to Search

Digital Community for HIV & Hepatitis C Prevention

N/A

Recruiting

Led By Dolores Albarracin, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months

Awards & highlights

Study Summary

This trial studies how to reduce HIV & HCV infections in areas with high risk due to injection drug use.

Who is the study for?

This trial is for adults living in specific high-risk areas of Appalachia and the Midwest, where there's a concern about HIV and Hepatitis C due to injection drug use. It includes those who have used illicit substances within the last month as well as those who haven't in the past year.Check my eligibility

What is being tested?

The study tests a 'Virtual Community Intervention' against the usual health practices (Standard of Care) to see if it can improve health outcomes related to infectious diseases like HIV and Hepatitis C in rural communities.See study design

What are the potential side effects?

Since this intervention is non-medical and involves digital community support, direct physical side effects are not expected. However, participants may experience stress or discomfort from discussing personal health issues online.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HCV Testing and Treatment

HIV Testing and Treatment

Harm Reduction and Substance Use Recovery Service Use

+2 more

Secondary outcome measures

Health Care Access

Stigmatizing Conversational Language

Substance Use

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Virtual Community InterventionExperimental Treatment1 Intervention

Participants will participate in an online community with structured sessions as well as the ability to communicate freely with others.

Group II: Standard of CareActive Control1 Intervention

Participants will be exposed to what's disseminated within their communities

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,687 Total Patients Enrolled

West Virginia UniversityOTHER

176 Previous Clinical Trials

59,614 Total Patients Enrolled

Dolores Albarracin, PhDPrincipal InvestigatorUniv. of Pennsylvania

1 Previous Clinical Trials

722 Total Patients Enrolled

Media Library

Virtual Community Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05363865 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Virtual Community Intervention, Standard of Care

Human Immunodeficiency Virus Infection Clinical Trial 2023: Virtual Community Intervention Highlights & Side Effects. Trial Name: NCT05363865 — N/A

Virtual Community Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05363865 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for individuals looking to take part in this experiment?

"Affirmative. Clinicaltrials.gov data suggests that this research project is actively recruiting participants, having first been posted on June 12th 2023 and last updated on July 10th 2023. 2400 patients are being sought from one location to take part in the trial."

Answered by AI

What sort of qualifications are needed to qualify for inclusion in this clinical experiment?

"Candidates for this medical study must have a human immunodeficiency virus infection and be aged between 18 to 99. The total patient capacity has been set at 2400 people."

Answered by AI

How many volunteers are taking part in this experiment?

"Affirmative. Clinicaltrials.gov attests that this medical trial, which was first posted on June 12th 2023, is actively recruiting participants. 2400 patients are needed to be enrolled from 1 clinical site."

Answered by AI

What is the overarching objective of this research endeavor?

"The main objective of this medical trial, which will be tracked for a period of around 12 months is the voluntary self-testing for hepatitis c virus (HCV). Secondary goals include gauging patient motivation to endorse harm reduction policies in their community (based on a scale from Very Likely to Very Unlikely), usage of pertinent harm reduction measures such as syringe exchange services and drug treatment, frequency with which Narcan is carried by participants (on average) and measuring willingness to get tested for HIV/HCV."

Answered by AI